尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Mileson Glenna, 首席财务官. Insider active across 1 company, notably Athira Pharma, Inc.. Cumulatively, 5 filings have been logged. History available since 18 May 2021. The latest transaction was filed on 18 November 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Glenna Mileson is the Chief Financial Officer at Athira Pharma, Inc. She is responsible for the company's financial management, including budgeting and financial strategy. Her role is crucial in ensuring the financial health of the company and supporting its growth in the pharmaceutical sector.